Product Information
SIROLIMUS 1 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.8350 per EA under NDC 59762100201. Its NADAC has been published 601 times since Feb 18, 2015.
FDA first approved this application on Aug 25, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762100201
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SIROLIMUSApproval Type
Authorized Generic (NDA)
FDA Application
NDA021110FDA Approved
8/25/2000
TE Code
AB
On Market Since
10/27/2014
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 1 MG TABLET has been published 601 times since Feb 18, 2015, and over the history we have for it it has declined 93.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8350 per EA |
|---|---|
| All-time high | $13.5260 (Apr 13, 2016) |
| All-time low | $0.8350 (Aug 19, 2026) |
| 52-week high | $1.6054 |
| 52-week low | $0.8350 |
| Median price | $6.9609 |
| Average price | $6.5208 |
| Largest weekly change | -38.5% (Nov 20, 2024) |
| Weeks tracked | 601 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SIROLIMUS market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SIROLIMUS 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.8350 per EA (NDC 59762100201), effective Aug 19, 2026.
How has the price of SIROLIMUS 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 1 MG TABLET has declined 93.3%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG TABLET?
Since Feb 18, 2015, the NADAC for SIROLIMUS 1 MG TABLET has ranged from a low of $0.8350 (Aug 19, 2026) to a high of $13.5260 (Apr 13, 2016), with a median of $6.9609 per EA.
Are there cheaper alternatives to SIROLIMUS 1 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SIROLIMUS 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SIROLIMUS 1 MG TABLET?
SIROLIMUS 1 MG TABLET (NDC 59762100201) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.